“The current predicament has uncovered some structural weaknesses within the EU’s medicines offer chain along with a significant dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides mentioned. She encouraged that offer chain challenges be addressed in an EU pharmaceutical approach expected to generally be introduc… Read More